Highly sensitive and rapid detection of SARS‐CoV‐2 via a portable CRISPR‐Cas13a‐based lateral flow assay

Abstract

To rapidly identify individuals infected with severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) and control the spread of coronavirus disease (COVID‐19), there is an urgent need for highly sensitive on‐site virus detection methods. A clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR‐associated protein (Cas)‐based molecular diagnostic method was developed for this purpose. Here, a CRISPR system‐mediated lateral flow assay (LFA) for SARS‐CoV‐2 was established based on multienzyme isothermal rapid amplification, CRISPR‐Cas13a nuclease, and LFA. To improve the limit of detection (LoD), the crispr RNA, amplification primer, and probe were screened, in addition to concentrations of various components in the reaction system. The LoD of CRISPR detection was improved to 0.25 copy/μl in both fluorescence‐ and immunochromatography‐based assays. To enhance the quality control of the CRISPR‐based LFA method, glyceraldehyde‐3‐phosphate dehydrogenase was detected as a reference using a triple‐line strip design in a lateral flow strip. In total, 52 COVID‐19‐positive and 101 COVID‐19‐negative clinical samples examined by reverse transcription polymerase chain reaction (RT‐PCR) were tested using the CRISPR immunochromatographic detection technique. Results revealed 100% consistency, indicating the comparable effectiveness of our method to that of RT‐PCR. In conclusion, this approach significantly improves the sensitivity and reliability of CRISPR‐mediated LFA and provides a crucial tool for on‐site detection of SARS‐CoV‐2.

Immunochromatographic enhancement strategy for SARS-CoV-2 detection based on nanotechnology

“…Liu et al developed a CRISPR-Cas13a-based immunochromatographic assay and designed three-line LFIA test strips for SARS-CoV-2 detection. 114 This method obtained comparable detection levels to RT-PCR assays with a LOD of 0.25 copies per μL and sensitivity of 100%. It should be noted that the CRISPR–immunochromatographic method allowed the test results to be reported within 1 h, thereby saving more than 30 min compared with RT-PCR.…”

Azvudine therapy of common COVID‐19 in hemodialysis patients

“…Samples were retested when the CT value was between 35 and 40. Repeated tests showed that a Ct value less than 40 was positive 14 …”

Nanoparticles Based on Prussian Blue for Biosensor Applications: A Review

“…Fluorescence-based immunoassay technology has attracted considerable attention owing to the development of numerous nanomaterials with good luminescence properties, 115 including quantum dots 116 and carbon dots. 117 However, most fluorescence immunoassays are based only on changes in the fluorescence intensity, which are susceptible to external interference. Liao et al 118 used PBNPs to bind goat antimouse antibodies to obtain a PBNP-antibody binding ratio fluorescence reading, which was then calibrated for different concentrations of histamine.…”